stalled for 18 weeks at 2.4mg and I refuse to panic this time
I have had 16 orders now and I keep a table, so here is the honest summary rather than a vibe.
Material has been consistent. Communication has not. Shipping has varied by about 20 days on nominally the same lane, which matters more in summer than in February.
The independent number came back 96.8% against a claimed 99.1%, which I read as agreement rather than a discrepancy — inter-lab variance on this assay is a point or two either way and treating one lab as ground truth is how people end up in pointless arguments with vendors.
Batch number is in the comments. Ask if you want the method.
best — the order this archive was captured in
the weight curves are unusually steep, which makes predicting individual response harder
The heart rate signal in TRIUMPH is real and concerning. Higher doses had higher mean HR changes.
Flair changed to match the content. Read the sidebar before posting next time and we are square.
phase 2 numbers are not maintenance numbers, cite the trial
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
retatrutide is not approved anywhere for human use, posts must not read as instructions
Mechanistically the bit that matters is dose escalation. It explains most of the early profile and a decent chunk of the outcome.